ABSTRACT
Escherichia coli has shown that genes governing sequential metabolic steps are not themselves adjacent. It is also known that the levels of certain such enzymes do not vary greatly with obvious metabolic need: hence they are "constitutive"-a term which reflects our ignorance about specific or general mechanisms regulating their synthesis (reviewed in ref. 1 ).
The present report shows cell-free synthesis of such an enzyme. We used DNA from a specialized transducing phage carrying the gene for 6-phosphogluconate dehydrogenase [6PGD; 6-phospho-D-gluconate:NADP 2-oxidoreductase (decarboxylating), EC Cell-Free Synthesis of 6PGD. Strain RW181 (F-trpR-, lacY-,trpA-,dgRc, (edd-zwf)A22,(sbcB-his-gnd-rfb)Ap2) lysogenized with the specialized transducing phage XcI857St68h80dgndhis (2) and the helper phage Xcd857St68h80 was the source of the DNA for cell-free synthesis of 6PGD. First a lysate was prepared by heat-induction and the phage were concentrated according to Zubay (3) . Then phage were purified by centrifugation twice in CsCl block gradients and XcI857St68h80dgndhis was separated from the helper phage of lower buoyant density by centrifugation to equilibrium in CsCl as described by Greenblatt (4). DNA was extracted according to Zubay (3) .
The cell-free extract for in vitro synthesis was prepared according to Zubay (3) as modified by Wilcox et al. (5) . A derivative of strain RW181 was used, laCX74 being introduced so that the efficiency of the extract could be monitored by in vitro synthesis and assay of ,B-galactosidase.
In Vitro Protein Synthesis. The components of the reaction mixture and conditions for protein synthesis were generally as described by Zubay (3) with exceptions noted in the legends to figures and tables.
Assay of 6PGD. 6PGD activity was determined by a radiochemical assay similar to one described by Brown and Wittenberger (6 vitro synthesis mixture in a volume of 0.9 ml. The center well contained 0.5 ml of Protosol (New England Nuclear). Serum bottle stoppers were inserted into the flasks which were then incubated at 30' for 15 min to permit temperature equilibration. The reaction was initiated by injecting NADP (0.1 ml of a 2 mM solution) through the stopper with a syringe. Flasks were incubated at 30°for 15 min to 3 hr, after which time the reaction was terminated by injection of 0.2 ml of 5 N H2SO4 into the main compartment. Flasks were transferred to 370 and incubation was continued for 1 hr at 160 rpm to ensure complete trapping in the center well of evolved 14CO2. The contents of the center well were transferred quantitatively to scintillation vials that contained 10 ml of 0.4% Omnifluor (New England Nuclear) in toluene The components of the reaction mixture and conditions for protein synthesis were as described by Zubay (3) except that the DNA concentration was 6 gg/ml, and the concentration of cell-free extract was 6.0 mg/ml. cAMP, NADP, FAD, pyridoxine-HCl, and p-aminobenzoic acid had no measurable effect on synthesis of 6PGD and were omitted. A Mg++ concentration of 12.7 mM gave optimal results. The final volume was 0.1 ml and synthesis was at 360 for 30 min. Synthesis was initiated by the addition of S-30 and terminated by chilling and adding chloramphenicol to 100 gg/ml. and counted in a Packard Tri-Carb liquid scintillation spectrophotometer. Twenty-two cpm were released nonenzymatically from assays lacking NADP or the cell-free extract and were subtracted from all enzyme assays. Initial rates were linear for more than 1 hr and were proportional to enzyme concentration in the ranges used. Enzyme activity is expressed as units of activity per ml of protein-synthesizing mixture, where one unit of enzyme is defined as the amount that catalyzes the release of 1 nmol of 14CO2 per min at 300.
RESULTS

In vitro synthesis of 6PGD
In vitro studies on the mechanism of expression of a particular gene are done best with a source of DNA enriched for the gene of interest, a cell-free extract (S-3O) prepared from a strain carrying a deletion of the gene, and a sensitive assay for the gene product. To detect the small amount of 6PGD synthesized in vitro we first prepared 6-phospho[1-14C]gluconate to serve as substrate and developed a radiochemical method for quantitating the amount of 14CO2 released as a product of the enzymatic reaction. The strain used for the preparation of the cell-free extract carried deletions of both gnd and edd and thus lacks both of the enzymes known to use 6-phosphogluconate as a substrate (1) . DNA Fig. 1) .
The results presented in Table 1 Time course of the initiation, synthesis, and translation of the mRNA for 6PGD. The conditions for protein synthesis and assay of 6PGD activity (units/ml) were as described in Table  1 . Separate flasks were used for each time point. Synthesis was initiated by addition of cell-free extract, and rifainpicin (4 jig/ml), actinomycin D (4 jig/ml), or chloramphenicol (100 ;g/ml) were added at each time point shown, and incubation was continued for an additional 30 min before chilling. 0, rifampicin; 0, actinomycin D; A, chloramphenicol.
XcI857St68h8Odgndhis DNA. However, 6PGD activity was detectable after incubation of the complete mixture. That activity, like authentic 6PGD, was dependent on 6-phosphogluconate and NADP and released 14CO2 at a linear rate for more than 1 hr. The amount of activity synthesized increased in proportion to the DNA concentration in the range of 0-10 gg/ml (data not shown).
Time course of enzyme synthesis and of the capacity to synthesize the mRNA We next wanted to determine the extent to which the in vitro synthesis of 6PGD represented the in vvo expression of gnd. With other systems the usual approach has been to attempt to reproduce in vitro a regulatory event thought to occur in vivo, e.g., the repression of fl-galactosidase synthesis by lac repressor, or its stimulation by cAMP (8) . However, such an approach is not possible for a gene whose regulatory properties are unknown. Thus we have studied instead the time course for the initiation, synthesis, and translation of the mRNA for 6PGD (Fig. 2) , the rationale being that the time for transcription and for enzyme synthesis would be a measure of the distance between the promoter at which transcription was initiated and the end of the structural gene. Inhibitors of either RNA number necessary to encode the 6PGD monomer. By extrapolation from the linear initial rates, the capacity to synthesize the mRNA for 6PGD becomes resistant to rifampicin by 1.5 min and to actinomycin D by 3 min (Fig. 2) . Thus, since rifampicin and actinomycin D inhibit the initiation and propagation of RNA synthesis, respectively, it follows that the time to synthesize the mRNA for 6PGD was about 1.5 min (3.0-1.5 = 1.5). At an in vitro transcription rate of about 19 nucleotides/sec (10) a mRNA approximately 1710 nucleotides long could be made in 1.5 min. The monomer of 6PGD is about 60,000 daltons (11, 12) , which would require a mRNA of 1500 nucleotides. Therefore, since the estimated length of the mRNA made in vitro is about the same as that required to encode the 6PGD monomer, it seems likely that in our cell-free system transcription was initiated at the gnd promoter.
The effect of cAMP and cGMP on the synthesis of 6PGD in vitro cAMP in conjunction with the cAMP receptor protein (CAP) is required for maximal expression of a number of inducible genes, but its effect on genes for enzymes of glycolysis and the hexose monophosphate shunt has not been reported (13) . Data presented in Fig. 3 (15, 16) and some of the ribosomal proteins (17, 18) have been synthesized in vitro. Based on previous work with genes for amino-acid biosynthesis and carbohydrate degradation, it seems likely that studies using systems like these will help to elucidate the mechanisms that regulate the synthesis of this important class of proteins.
Our in vivo studies (to be reported) with Xc1857St68h80dgndhis lysogens indicated that the phage carries the structural gene for 6PGD, and that synthesis of the enzyme from the prophage is constitutive and not under control of a phage promoter. The experiments reported here have shown that in our cell-free system the synthesis of the mRNA for 6PGD was probably initiated at the gnd promoter, a necessary condition if the system is to be useful in subsequent study of the mechanisms that regulate expression of the gene. It should be pointed out, however, that the kinetic experiments (Fig. 2) do not rule out the possibility that readthrough transcription contributes to the total amount of enzyme made. Nonetheless, since at least some transcription was initiated at the gnd promoter, and since the synthesis of fl-galactosidase with the same cell-free extract showed normal cAMP dependence, the fact that cAMP was without effect on the in vitro synthesis of 6PGD strongly suggests that it is not a regulator of gnd in viso. Moreover, because similar results were obtained for the in vitro synthesis of ribosomal proteins (17) and the j3 subunit of RNA polymerase (15) , it would appear that in general the synthesis of constitutive proteins is not subject to regulation by the cAMP-CAP system.
We next calculate the efficiency of our in vitro system and compare it to other systems. The initial rate of appearance of 6PGD activity, as determined from the slope of the curve in the rifampicin experiment (Fig. 2) , was about 90 units/hr per ml of synthesis mixture. The DNA concentration in the experiment was 6 qg/ml. Thus the rate per genome was about 7.5 X 10-10 units/hr, given Avogadro's number and assuming the molecular weight of XcI857St68h80dgndhis DNA to be 30 X 106 and that all genomes were functional. The in vvo rate per genome would be about 7.5 X 10-9 units/hr for cells growing at a rate of one mass doubling per hr where the specific activity is about 150 units/mg (19) , assuming 2 genomes and 10-10 mg of soluble protein per cell. (We note that the value would vary according to the effect of growth rate on the in vio rate of enzyme synthesis.) Thus the approximate efficiency of our system (10%), expressed as the percent of the in vivo rate per genome, is as high as any previously reported [arabinose isomerase, 5% (5); tryptophan synthetase, 2-10% (20); galactokinase, about 0.1% (21) ; N-a-acetyl ornithinase, 0.09% (22) ]. However, since the rate-limiting step in the in vitro synthesis of 6PGD is unknown, the possibility cannot be ruled out that the overall rate is limited by the action of a repressor, or the lack of action of a positive regulator. Subsequent studies using such a system may help determine what mechanisms actually regulate the synthesis of 6PGD.
